Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of ReMindCare Application for Smartphone in Treatment of Patients From First Episode of Psychosis Unit in the Clinic Hospital of Valencia, Spain.

NCT03807388 is registered in ClinicalTrials.gov with Instituto de Investigacion Sanitaria INCLIVA as lead sponsor.

NCT NCT03807388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03807388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of ReMindCare Application for Smartphone in Treatment of Patients From First Episode of Psychosis Unit in the Clinic Hospital of Valencia, Spain.
Lead sponsor
Instituto de Investigacion Sanitaria INCLIVA
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2019
Completion date
September 30, 2023
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, medication, delirium, hallucinations, psychosis, psychotic disorders, schizophrenia, treatment side effects